{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:24Z","timestamp":1791835824108,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00134-025-08151-1","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:28:03Z","timestamp":1761035283000},"page":"2065-2078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-4063","authenticated-orcid":false,"given":"Ignacio","family":"Martin-Loeches","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Guinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souha S.","family":"Kanj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"4","key":"8151_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/jof11040258","volume":"11","author":"JA Vazquez","year":"2025","unstructured":"Vazquez JA, Whitaker L, Zubovskaia A (2025) Invasive candidiasis in the intensive care unit: where are we now? J Fungi (Basel) 11(4):258","journal-title":"J Fungi (Basel)"},{"key":"8151_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/ofid\/ofaf359","volume":"12","author":"A Soriano-Mart\u00edn","year":"2025","unstructured":"Soriano-Mart\u00edn A, Escribano P, Machado M, Guinea J, Reigadas E, Garc\u00eda-Clemente P, Bouza E, Mu\u00f1oz P (2025) Trends in Candidemia Over the Last 14 Years: a comparative analysis of Candida parapsilosis and Candida albicans. Open Forum Infect Dis 12:359","journal-title":"Open Forum Infect Dis"},{"key":"8151_CR3","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW (2024) Global incidence and mortality of severe fungal disease. Lancet Infect Dis 24:e428\u2013e438","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"8151_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/jof11020152","volume":"11","author":"BL de Almeida","year":"2025","unstructured":"de Almeida BL, Agnelli C, Guimar\u00e3es T, Sukiennik T, Lima PRP, Salles MJC, Breda GL, Queiroz-Telles F, Mendes AVA, Camargo LFA, Morales HMP, Dias V, da Silva Junior AR, de Almeida Junior JN, Picone CM, de Ara\u00fajo E, Abdala E, Rossi F, Colombo AL, Magri MMC (2025) Candidemia in ICU patients: what are the real game-changers for survival? J Fungi (Basel) 11(2):152","journal-title":"J Fungi (Basel)"},{"key":"8151_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13613-019-0539-2","volume":"9","author":"E Ghrenassia","year":"2019","unstructured":"Ghrenassia E, Mokart D, Mayaux J, Demoule A, Rezine I, Kerhuel L, Calvet L, De Jong A, Azoulay E, Darmon M (2019) Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study. Ann Intensive Care 9:62","journal-title":"Ann Intensive Care"},{"key":"8151_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Fl\u00f6rl","year":"2024","unstructured":"Lass-Fl\u00f6rl C, Kanj SS, Govender NP, Thompson GR 3rd, Ostrosky-Zeichner L, Govrins MA (2024) Invasive candidiasis Nat Rev Dis Primers 10:20","journal-title":"Invasive candidiasis Nat Rev Dis Primers"},{"key":"8151_CR7","doi-asserted-by":"publisher","unstructured":"Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, Lass-Fl\u00f6rl C, Ostrosky-Zeichner L, Rautemaa-Richardson R, Revathi G, Santolaya ME, White PL, Alastruey-Izquierdo A, Arendrup MC, Baddley J, Barac A, Ben-Ami R, Brink AJ, Grothe JH, Guinea J, Hagen F, Hochhegger B, Hoenigl M, Husain S, Jabeen K, Jensen HE, Kanj SS, Koehler P, Lehrnbecher T, Lewis RE, Meis JF, Nguyen MH, Pana ZD, Rath PM, Reinhold I, Seidel D, Takazono T, Vinh DC, Zhang SX, Afeltra J, Al-Hatmi AMS, Arastehfar A, Arikan-Akdagli S, Bongomin F, Carlesse F, Chayakulkeeree M, Chai LYA, Chamani-Tabriz L, Chiller T, Chowdhary A, Clancy CJ, Colombo AL, Cortegiani A, Corzo Leon DE, Drgona L, Dudakova A, Farooqi J, Gago S, Ilkit M, Jenks JD, Klimko N, Krause R, Kumar A, Lagrou K, Lionakis MS, Lmimouni BE, Mansour MK, Meletiadis J, Mellinghoff SC, Mer M, Mikulska M, Montravers P, Neoh CF, Ozenci V, Pagano L, Pappas P, Patterson TF, Puerta-Alcalde P, Rahimli L, Rahn S, Roilides E, Rotstein C, Ruegamer T, Sabino R, Salmanton-Garc\u00eda J, Schwartz IS, Segal E, Sidharthan N, Singhal T, Sinko J, Soman R, Spec A, Steinmann J, Stemler J, Taj-Aldeen SJ, Talento AF, Thompson GR, 3rd, Toebben C, Villanueva-Lozano H, Wahyuningsih R, Weinbergerov\u00e1 B, Wiederhold N, Willinger B, Woo PCY, Zhu LP, (2025) Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis 25(suppl 7). https:\/\/doi.org\/10.1016\/S1473-3099(24)00749-7","DOI":"10.1016\/S1473-3099(24)00749-7"},{"key":"8151_CR8","doi-asserted-by":"publisher","first-page":"0092022","DOI":"10.1128\/mbio.00920-22","volume":"13","author":"S Bretagne","year":"2022","unstructured":"Bretagne S, Sitbon K, Desnos-Ollivier M, Garcia-Hermoso D, Letscher-Bru V, Cassaing S, Millon L, Morio F, Gangneux JP, Hasseine L, Favennec L, Cateau E, Bailly E, Moniot M, Bonhomme J, Desbois-Nogard N, Chouaki T, Paugam A, Bouteille B, Pihet M, Dalle F, Eloy O, Sasso M, Demar M, Mariani-Kurkdjian P, Robert V, Lortholary O, Dromer F (2022) Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF network (2012\u20132018). MBio 13:0092022","journal-title":"MBio"},{"issue":"1","key":"8151_CR9","doi-asserted-by":"publisher","first-page":"106513","DOI":"10.1016\/j.jinf.2025.106513","volume":"91","author":"AG Stewart","year":"2025","unstructured":"Stewart AG, Laupland KB, Edwards F, Koo S, Hammond SP, Harris PNA, Paterson DL, Slavin MA, Chen SCA (2025) Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance. J Infect 91(1):106513","journal-title":"J Infect"},{"key":"8151_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","volume":"23","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi M-P, Atchade E, Azzini AM, Carannante N, Carnelutti A, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, Garc\u00eda-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Le Bihan C, Luzzati R, Malbrain MLNG, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva J-A, Peghin M, Raineri SM, Rautemaa-Richardson R, Schouten J, Brugnaro P, Spapen H, Tasioudis P, Timsit J-F, Tisa V, Tumbarello M, van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Montravers P (2019) Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care 23:219","journal-title":"Crit Care"},{"key":"8151_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13613-020-00755-8","volume":"10","author":"M Schroeder","year":"2020","unstructured":"Schroeder M, Weber T, Denker T, Winterland S, Wichmann D, Rohde H, Ozga A-K, Fischer M, Kluge S (2020) Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis. Ann Intensive Care 10:142","journal-title":"Ann Intensive Care"},{"key":"8151_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/CLEP.S459600","volume":"16","author":"DJ Bays","year":"2024","unstructured":"Bays DJ, Jenkins EN, Lyman M, Chiller T, Strong N, Ostrosky-Zeichner L, Hoenigl M, Pappas PG, Thompson Iii GR (2024) Epidemiology of Invasive Candidiasis. Clin Epidemiol 16:549\u2013566","journal-title":"Clin Epidemiol"},{"key":"8151_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","volume":"87","author":"MC Arendrup","year":"2023","unstructured":"Arendrup MC, Arikan-Akdagli S, J\u00f8rgensen KM, Barac A, Steinmann J, Toscano C, Arsenijevic VA, Sartor A, Lass-Fl\u00f6rl C, Hamprecht A, Matos T, Rogers BRS, Quiles I, Buil J, \u00d6zenci V, Krause R, Bassetti M, Loughlin L, Denis B, Grancini A, White PL, Lagrou K, Willinger B, Rautemaa-Richardson R, Hamal P, Ener B, Unalan-Altintop T, Evren E, Hilmioglu-Polat S, Oz Y, Ozyurt OK, Aydin F, R\u016f\u017ei\u010dka F, Meijer EFJ, Gangneux JP, Lockhart DEA, Khanna N, Logan C, Scharmann U, Desoubeaux G, Roilides E, Talento AF, van Dijk K, Koehler P, Salmanton-Garc\u00eda J, Cornely OA, Hoenigl M (2023) European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM <em>Candida<\/em> III study. J Infect 87:428\u2013437","journal-title":"J Infect"},{"issue":"6","key":"8151_CR14","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","volume":"4","author":"F Daneshnia","year":"2023","unstructured":"Daneshnia F, de Almeida J\u00fanior JN, Ilkit M, Lombardi L, Perry AM, Gao M, Nobile CJ, Egger M, Perlin DS, Zhai B, Hohl TM, Gabald\u00f3n T, Colombo AL, Hoenigl M, Arastehfar A (2023) Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe 4(6):e470\u2013e480","journal-title":"Lancet Microbe"},{"key":"8151_CR15","doi-asserted-by":"publisher","first-page":"100949","DOI":"10.1016\/j.lanmic.2024.07.012","volume":"6","author":"PJT Brassington","year":"2025","unstructured":"Brassington PJT, Klefisch FR, Graf B, Pf\u00fcller R, Kurzai O, Walther G, Barber AE (2025) Genomic reconstruction of an azole-resistant Candida parapsilosis outbreak and the creation of a multi-locus sequence typing scheme: a retrospective observational and genomic epidemiology study. Lancet Microbe 6:100949","journal-title":"Lancet Microbe"},{"key":"8151_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7326\/M22-3469","volume":"176","author":"M Lyman","year":"2023","unstructured":"Lyman M, Forsberg K, Sexton DJ, Chow NA, Lockhart SR, Jackson BR, Chiller T (2023) Worsening Spread of Candida auris in the United States, 2019 to 2021. Ann Intern Med 176:489\u2013495","journal-title":"Ann Intern Med"},{"key":"8151_CR17","doi-asserted-by":"publisher","first-page":"105799","DOI":"10.1016\/j.ijantimicag.2019.09.003","volume":"55","author":"M Castanheira","year":"2020","unstructured":"Castanheira M, Deshpande LM, Messer SA, Rhomberg PR, Pfaller MA (2020) Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Int J Antimicrob Agents 55:105799","journal-title":"Int J Antimicrob Agents"},{"key":"8151_CR18","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.jiph.2023.08.015","volume":"16","author":"TB Tufa","year":"2023","unstructured":"Tufa TB, Bongomin F, Fathallah A, C\u00e2ndido ALSM, Hashad R, Abdallaoui MS, Nail AA, Fayemiwo SA, Penney ROS, Orefuwa E, Denning DW (2023) Access to the World Health Organization-recommended essential diagnostics for invasive fungal infections in critical care and cancer patients in Africa: a diagnostic survey. J Infect Public Health 16:1666\u20131674","journal-title":"J Infect Public Health"},{"key":"8151_CR19","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","volume":"21","author":"BH Tan","year":"2015","unstructured":"Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, Chindamporn A, Tan AL, Sun PL, Wu UI, Chen YC (2015) Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 21:946\u2013953","journal-title":"Clin Microbiol Infect"},{"key":"8151_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jiph.2019.03.009","volume":"12","author":"W Alfouzan","year":"2019","unstructured":"Alfouzan W, Dhar R, Albarrag A, Al-Abdely H (2019) The emerging pathogen Candida auris: a focus on the Middle-Eastern countries. J Infect Public Health 12:451\u2013459","journal-title":"J Infect Public Health"},{"issue":"1","key":"8151_CR21","doi-asserted-by":"publisher","first-page":"ofac559","DOI":"10.1093\/ofid\/ofac559","volume":"10","author":"SE Kidd","year":"2023","unstructured":"Kidd SE, Abdolrasouli A, Hagen F (2023) Fungal nomenclature: managing change is the name of the game. Open Forum Infect Dis 10(1):ofac559","journal-title":"Open Forum Infect Dis"},{"key":"8151_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","volume":"161","author":"DO Thomas-R\u00fcddel","year":"2022","unstructured":"Thomas-R\u00fcddel DO, Schlattmann P, Pletz M, Kurzai O, Bloos F (2022) Risk factors for invasive candida infection in critically Ill patients: a systematic review and meta-analysis. Chest 161:345\u2013355","journal-title":"Chest"},{"key":"8151_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijid.2020.10.092","volume":"102","author":"H Alenazy","year":"2021","unstructured":"Alenazy H, Alghamdi A, Pinto R, Daneman N (2021) Candida colonization as a predictor of invasive candidiasis in non-neutropenic ICU patients with sepsis: a systematic review and meta-analysis. Int J Infect Dis 102:357\u2013362","journal-title":"Int J Infect Dis"},{"issue":"5","key":"8151_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.01909-17","volume":"56","author":"CJ Clancy","year":"2018","unstructured":"Clancy CJ, Nguyen MH (2018) Diagnosing invasive candidiasis. J Clin Microbiol 56(5):10\u20131128","journal-title":"J Clin Microbiol"},{"key":"8151_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1128\/JCM.01602-10","volume":"49","author":"T Avni","year":"2011","unstructured":"Avni T, Leibovici L, Paul M (2011) PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 49:665\u2013670","journal-title":"J Clin Microbiol"},{"issue":"3","key":"8151_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.02004-18","volume":"63","author":"M Bordallo-Cardona","year":"2019","unstructured":"Bordallo-Cardona M, S\u00e1nchez-Carrillo C, Bouza E, Mu\u00f1oz P, Escribano P, Guinea J (2019) Detection of echinocandin-resistant candida glabrata in blood cultures spiked with different percentages of FKS2 mutants. Antimicrob Agents Chemother 63(3):10\u20131128","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"8151_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00162-18","volume":"62","author":"M Bordallo-Cardona","year":"2018","unstructured":"Bordallo-Cardona M, Marcos-Zambrano LJ, S\u00e1nchez-Carrillo C, Bouza E, Mu\u00f1oz P, Escribano P, Guinea J (2018) Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples. Antimicrob Agents Chemother 62(6):10\u2013128","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"8151_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00400-17","volume":"61","author":"P Escribano","year":"2017","unstructured":"Escribano P, Marcos-Zambrano LJ, G\u00f3mez A, S\u00e1nchez C, Mart\u00ednez-Jim\u00e9nez MC, Bouza E, Guinea J (2017) The etest performed directly on blood culture bottles is a reliable tool for detection of fluconazole-resistant candida albicans isolates. Antimicrob Agents Chemother 61(7):10\u2013128","journal-title":"Antimicrob Agents Chemother"},{"key":"8151_CR29","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1093\/jac\/dkv241","volume":"70","author":"MC Mart\u00ednez-Jim\u00e9nez","year":"2015","unstructured":"Mart\u00ednez-Jim\u00e9nez MC, Mu\u00f1oz P, Valerio M, Vena A, Guinea J, Bouza E (2015) Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment. J Antimicrob Chemother 70:3107\u20133115","journal-title":"J Antimicrob Chemother"},{"key":"8151_CR30","doi-asserted-by":"publisher","first-page":"E129","DOI":"10.1111\/1469-0691.12096","volume":"19","author":"E Bouza","year":"2013","unstructured":"Bouza E, Alcal\u00e1 L, Mu\u00f1oz P, Mart\u00edn-Rabad\u00e1n P, Guembe M, Rodr\u00edguez-Cr\u00e9ixems M (2013) Can microbiologists help to assess catheter involvement in candidaemic patients before removal? Clin Microbiol Infect 19:E129-135","journal-title":"Clin Microbiol Infect"},{"key":"8151_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/cc11202","volume":"16","author":"A Afshari","year":"2012","unstructured":"Afshari A, Schrenzel J, Ieven M, Harbarth S (2012) Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection\u2013a new frontier? Crit Care 16:222","journal-title":"Crit Care"},{"key":"8151_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37201\/req\/112.2023","volume":"37","author":"A Soriano-Mart\u00edn","year":"2024","unstructured":"Soriano-Mart\u00edn A, Mu\u00f1oz P, Garc\u00eda-Rodr\u00edguez J, Cant\u00f3n R, Vena A, Bassetti M, Bouza E (2024) Unresolved issues in the diagnosis of catheter related candidemia: a position paper. Rev Esp Quimioter 37:1\u201316","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"8151_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jof7010014","volume":"7","author":"MA Finkelman","year":"2020","unstructured":"Finkelman MA (2020) Specificity influences in (1\u21923)-\u03b2-d-Glucan-supported diagnosis of invasive fungal disease. J Fungi (Basel) 7(1):14. https:\/\/doi.org\/10.3390\/jof7010014","journal-title":"J Fungi (Basel)"},{"key":"8151_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/IDR.S181489","volume":"12","author":"R Murri","year":"2019","unstructured":"Murri R, Camici M, Posteraro B, Giovannenze F, Taccari F, Ventura G, Scoppettuolo G, Sanguinetti M, Cauda R, Fantoni M (2019) Performance evaluation of the (1,3)-\u03b2-D-glucan detection assay in non-intensive care unit adult patients. Infect Drug Resist 12:19\u201324","journal-title":"Infect Drug Resist"},{"issue":"9","key":"8151_CR35","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1111\/liv.15648","volume":"43","author":"M Egger","year":"2023","unstructured":"Egger M, Horvath A, Pr\u00fcller F, Fickert P, Finkelman M, Kriegl L, Gr\u00f8nbaek H, M\u00f8ller HJ, Prattes J, Krause R, Hoenigl M, Stadlbauer V (2023) Fungal translocation measured by serum 1,3-\u00df-D-glucan correlates with severity and outcome of liver cirrhosis-a pilot study. Liver Int 43(9):1975\u20131983","journal-title":"Liver Int"},{"key":"8151_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1365-2141.2002.03414.x","volume":"117","author":"M Kami","year":"2002","unstructured":"Kami M, Machida U, Okuzumi K, Matsumura T, Mori Si S, Hori A, Kashima T, Kanda Y, Takaue Y, Sakamaki H, Hirai H, Yoneyama A, Mutou Y (2002) Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy. Br J Haematol 117:40\u201346","journal-title":"Br J Haematol"},{"key":"8151_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/29768675241304684","author":"E Nopp\u00e8","year":"2024","unstructured":"Nopp\u00e8 E, Eloff JRP, Keane S, Martin-Loeches I (2024) A Narrative Review of Invasive Candidiasis in the Intensive Care Unit. Ther Adv Pulm Crit Care Med. https:\/\/doi.org\/10.1177\/29768675241304684","journal-title":"Ther Adv Pulm Crit Care Med"},{"issue":"2","key":"8151_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/jof4020045","volume":"4","author":"IM Zacharioudakis","year":"2018","unstructured":"Zacharioudakis IM, Zervou FN, Mylonakis E (2018) T2 magnetic resonance assay: overview of available data and clinical implications. J Fungi (Basel) 4(2):45","journal-title":"J Fungi (Basel)"},{"key":"8151_CR39","doi-asserted-by":"publisher","first-page":"iv6","DOI":"10.1093\/jac\/dky047","volume":"73","author":"P Mu\u00f1oz","year":"2018","unstructured":"Mu\u00f1oz P, Vena A, Machado M, Gioia F, Mart\u00ednez-Jim\u00e9nez MC, G\u00f3mez E, Orig\u00fcen J, Orellana M, L\u00f3pez-Medrano F, Fern\u00e1ndez-Ruiz M, Merino P, Gonz\u00e1lez-Romo F, Fr\u00edas I, P\u00e9rez-Granda MJ, Aguado JM, Fort\u00fan J, Bouza E (2018) T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study. J Antimicrob Chemother 73:iv6\u2013iv12","journal-title":"J Antimicrob Chemother"},{"key":"8151_CR40","doi-asserted-by":"publisher","first-page":"iv13","DOI":"10.1093\/jac\/dky048","volume":"73","author":"P Mu\u00f1oz","year":"2018","unstructured":"Mu\u00f1oz P, Vena A, Machado M, Mart\u00ednez-Jim\u00e9nez MC, Gioia F, G\u00f3mez E, Orig\u00fcen J, Orellana M, L\u00f3pez-Medrano F, P\u00e9rez-Granda MJ, Aguado JM, Fort\u00fan J, Bouza E (2018) T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study. J Antimicrob Chemother 73:iv13\u2013iv19","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"8151_CR41","doi-asserted-by":"publisher","first-page":"myad029","DOI":"10.1093\/mmy\/myad029","volume":"61","author":"\u00c9 Nourry","year":"2023","unstructured":"Nourry \u00c9, Wallet F, Darien M, Menotti J, Dupont D, Allaouchiche B, Argaud L, Richard JC, Guichon C, Rimmel\u00e9 T, Bohe J, Thioll\u00e8re F, Vassal O, Lepape A, Wallon M, Persat F, Friggeri A (2023) Use of 1,3-Beta-D-Glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal Candidiasis in Critically-ill patients. Med Mycol 61(3):myad029","journal-title":"Med Mycol"},{"key":"8151_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00069-00019","author":"EL Berkow","year":"2020","unstructured":"Berkow EL, Lockhart SR, Ostrosky-Zeichner L (2020) Antifungal susceptibility testing: current approaches. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/cmr.00069-00019","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"8151_CR43","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/microorganisms13030652","volume":"13","author":"A Bhargava","year":"2025","unstructured":"Bhargava A, Klamer K, Sharma M, Ortiz D, Saravolatz L (2025) Candida auris: a continuing threat. Microorganisms 13(3):652","journal-title":"Microorganisms"},{"key":"8151_CR44","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1093\/cid\/ciad109","volume":"76","author":"M Castanheira","year":"2023","unstructured":"Castanheira M, Mendes RE, Gales AC (2023) Global epidemiology and mechanisms of resistance of Acinetobacter baumannii-calcoaceticus complex. Clin Infect Dis 76:S166-s178","journal-title":"Clin Infect Dis"},{"key":"8151_CR45","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/cid\/ciad752","volume":"78","author":"SE Sansom","year":"2024","unstructured":"Sansom SE, Gussin GM, Schoeny M, Singh RD, Adil H, Bell P, Benson EC, Bittencourt CE, Black S, Del Marvillanueva Guzman M, Froilan MC, Fukuda C, Barsegyan K, Gough E, Lyman M, Makhija J, Marron S, Mikhail L, Noble-Wang J, Pacilli M, Pedroza R, Saavedra R, Sexton DJ, Shimabukuro J, Thotapalli L, Zahn M, Huang SS, Hayden MK (2024) Rapid environmental contamination with candida auris and multidrug-resistant bacterial pathogens near colonized patients. Clin Infect Dis 78:1276\u20131284","journal-title":"Clin Infect Dis"},{"key":"8151_CR46","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/13693780802415556","volume":"47","author":"J Guinea","year":"2009","unstructured":"Guinea J, Pel\u00e1ez T, Rodr\u00edguez-Cr\u00e9ixems M, Torres-Narbona M, Mu\u00f1oz P, Alcal\u00e1 L, Bouza E (2009) Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents? Med Mycol 47:515\u2013520","journal-title":"Med Mycol"},{"key":"8151_CR47","doi-asserted-by":"publisher","first-page":"eadi0908","DOI":"10.1126\/science.adi0908","volume":"385","author":"A Weimann","year":"2024","unstructured":"Weimann A, Dinan AM, Ruis C, Bernut A, Pont S, Brown K, Ryan J, Santos L, Ellison L, Ukor E, Pandurangan AP, Krokowski S, Blundell TL, Welch M, Blane B, Judge K, Bousfield R, Brown N, Bryant JM, Kukavica-Ibrulj I, Rampioni G, Leoni L, Harrison PT, Peacock SJ, Thomson NR, Gauthier J, Fothergill JL, Levesque RC, Parkhill J, Floto RA (2024) Evolution and host-specific adaptation of Pseudomonas aeruginosa. Science 385:eadi0908","journal-title":"Science"},{"key":"8151_CR48","doi-asserted-by":"publisher","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","volume":"5","author":"LE Cowen","year":"2014","unstructured":"Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS (2014) Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med 5:a019752","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 6","key":"8151_CR49","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/cid\/civ791","volume":"61","author":"DS Perlin","year":"2015","unstructured":"Perlin DS (2015) Echinocandin resistance in Candida. Clin Infect Dis 61(Suppl 6):S612-617","journal-title":"Clin Infect Dis"},{"key":"8151_CR50","first-page":"100354","volume":"8","author":"LS Ramos","year":"2025","unstructured":"Ramos LS, Barbosa PF, Lorentino CMA, Lima JC, Braga AL, Lima RV, Giovanini L, Casemiro AL, Siqueira NLM, Costa SC, Rodrigues CF, Roudbary M, Branquinha MH, Santos ALS (2025) The multidrug-resistant Candida auris, Candida haemulonii complex and phylogenetic related species: Insights into antifungal resistance mechanisms. Curr Res Microb Sci 8:100354","journal-title":"Curr Res Microb Sci"},{"key":"8151_CR51","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3389\/fmicb.2017.01927","volume":"8","author":"DL Zuza-Alves","year":"2017","unstructured":"Zuza-Alves DL, Silva-Rocha WP, Chaves GM (2017) An update on candida tropicalis based on basic and clinical approaches. Front Microbiol 8:1927","journal-title":"Front Microbiol"},{"key":"8151_CR52","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","volume":"38","author":"C Agnelli","year":"2019","unstructured":"Agnelli C, Valerio M, Bouza E, Vena A, Guinea J, del Carmen M-J, Marcos-Zambrano LJ, Escribano P, Mu\u00f1oz P, on behalf of the CSG (2019) Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era. Eur J Clin Microbiol Infect Dis 38:607\u2013614","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"8151_CR53","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.cmi.2024.07.002","volume":"30","author":"J Guinea","year":"2024","unstructured":"Guinea J, Alcoceba E, Padilla E, Ram\u00edrez A, De Carolis E, Sanguinetti M, Mu\u00f1oz-Algarra M, Dur\u00e1n-Valle T, Quiles-Melero I, Merino P, Gonz\u00e1lez-Romo F, S\u00e1nchez-Garc\u00eda A, G\u00f3mez-Garc\u00eda-de-la-Pedrosa E, P\u00e9rez-Ayala A, Mantec\u00f3n-Vallejo M, Pem\u00e1n J, Cu\u00e9tara MS, Zurita ND, Garc\u00eda-Esteban C, Mart\u00ednez-Jim\u00e9nez MDC, S\u00e1nchez Castellano M, Reigadas E, Mu\u00f1oz P, Escribano P (2024) Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme. Clin Microbiol Infect 30:1447\u20131452","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"8151_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00069-19","volume":"33","author":"EL Berkow","year":"2020","unstructured":"Berkow EL, Lockhart SR, Ostrosky-Zeichner L (2020) Antifungal susceptibility testing: current approaches. Clin Microbiol Rev 33(3):10\u20131128","journal-title":"Clin Microbiol Rev"},{"key":"8151_CR55","doi-asserted-by":"publisher","first-page":"e0140930","DOI":"10.1371\/journal.pone.0140930","volume":"10","author":"M Fung","year":"2015","unstructured":"Fung M, Kim J, Marty FM, Schwarzinger M, Koo S (2015) Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia. PLoS ONE 10:e0140930","journal-title":"PLoS ONE"},{"key":"8151_CR56","doi-asserted-by":"publisher","first-page":"ofac234","DOI":"10.1093\/ofid\/ofac234","volume":"9","author":"A Chakrabarti","year":"2022","unstructured":"Chakrabarti A, Mohamed N, Capparella MR, Townsend A, Sung AH, Yura R, Mu\u00f1oz P (2022) The role of diagnostics-driven antifungal stewardship in the management of invasive fungal infections: a systematic literature review. Open Forum Infect Dis 9:ofac234","journal-title":"Open Forum Infect Dis"},{"key":"8151_CR57","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","volume":"222","author":"MD Johnson","year":"2020","unstructured":"Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR III, Andes DR, Walsh TJ, Pappas PG, Cornely OA, Perfect JR, Kontoyiannis DP, Education ftMSG, Consortium R (2020) Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis 222:S175\u2013S198","journal-title":"J Infect Dis"},{"key":"8151_CR58","doi-asserted-by":"publisher","first-page":"106586","DOI":"10.1016\/j.jinf.2025.106586","volume":"91","author":"G Tiseo","year":"2025","unstructured":"Tiseo G, Vena A, Bassetti M, Bartalucci C, Cerchiaro M, Cesaretti M, Marchese A, Di Pilato V, Escribano P, Forniti A, Giacobbe DR, Guinea J, Limongelli A, Lupetti A, Machado M, Mikulska M, Salmanton-Garc\u00eda J, Soriano-Martin A, Taramasso L, Valerio M, Bouza E, Mu\u00f1oz P, Falcone M (2025) Persistent candidemia caused by different Candida species: data from a multicenter contemporary cohort. J Infect 91:106586","journal-title":"J Infect"},{"key":"8151_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmi.2015.09.029","volume":"22","author":"G Cuervo","year":"2016","unstructured":"Cuervo G, Garcia-Vidal C, Nucci M, Puchades F, Fern\u00e1ndez-Ruiz M, Obed M, Manzur A, Gudiol C, Pem\u00e1n J, Aguado JM, Ayats J, Carratal\u00e0 J (2016) Breakthrough candidaemia in the era of broad-spectrum antifungal therapies. Clin Microbiol Infect 22:181\u2013188","journal-title":"Clin Microbiol Infect"},{"key":"8151_CR60","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/myc.12960","volume":"62","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Hoenigl M, Lass-Fl\u00f6rl C, Chen SC, Kontoyiannis DP, Morrissey CO, Thompson GR 3rd (2019) Defining breakthrough invasive fungal infection-position paper of the mycoses study group education and research consortium and the European confederation of medical mycology. Mycoses 62:716\u2013729","journal-title":"Mycoses"},{"key":"8151_CR61","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42:1749\u20131755","journal-title":"Crit Care Med"},{"key":"8151_CR62","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","volume":"49","author":"M Morrell","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640\u20133645","journal-title":"Antimicrob Agents Chemother"},{"key":"8151_CR63","doi-asserted-by":"publisher","first-page":"ofz251","DOI":"10.1093\/ofid\/ofz251","volume":"6","author":"M Falcone","year":"2019","unstructured":"Falcone M, Tiseo G, Guti\u00e9rrez-Guti\u00e9rrez B, Raponi G, Carfagna P, Rosin C, Luzzati R, Delle Rose D, Andreoni M, Farcomeni A, Venditti M, Rodr\u00edguez-Ba\u00f1o J, Menichetti F (2019) Impact of initial antifungal therapy on the outcome of patients with candidemia and septic shock admitted to medical wards: a propensity score-adjusted analysis. Open Forum Infect Dis 6:ofz251","journal-title":"Open Forum Infect Dis"},{"key":"8151_CR64","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2016.14655","volume":"316","author":"JF Timsit","year":"2016","unstructured":"Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555\u20131564","journal-title":"JAMA"},{"key":"8151_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13613-018-0392-8","volume":"8","author":"K Jaffal","year":"2018","unstructured":"Jaffal K, Poissy J, Rouze A, Preau S, Sendid B, Cornu M, Nseir S (2018) De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety. Ann Intensive Care 8:49","journal-title":"Ann Intensive Care"},{"key":"8151_CR66","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","volume":"45","author":"I Martin-Loeches","year":"2019","unstructured":"Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, Garnacho-Montero J, Kanj SS, Machado FR, Montravers P, Sakr Y, Sanguinetti M, Timsit JF, Bassetti M (2019) ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med 45:789\u2013805","journal-title":"Intensive Care Med"},{"key":"8151_CR67","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/cid\/ciae603","volume":"80","author":"A Vena","year":"2025","unstructured":"Vena A, Tiseo G, Falcone M, Bartalucci C, Marelli C, Cesaretti M, Di Pilato V, Escribano P, Forniti A, Giacobbe DR, Guinea J, Limongelli A, Lupetti A, Machado M, Mikulska M, Salmanton-Garc\u00eda J, Soriano-Martin A, Taramasso L, Valerio M, Bouza E, Mu\u00f1oz P, Bassetti M (2025) Impact of fluconazole resistance on the outcomes of patients with Candida parapsilosis bloodstream infections: a retrospective multicenter study. Clin Infect Dis 80:540\u2013550","journal-title":"Clin Infect Dis"},{"key":"8151_CR68","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M, Chen SCA, Groll AH, Kurzai O, Lass-Fl\u00f6rl C, Ostrosky-Zeichner L, Rautemaa-Richardson R, Revathi G, Santolaya ME, White PL, Alastruey-Izquierdo A, Arendrup MC, Baddley J, Barac A, Ben-Ami R, Brink AJ, Grothe JH, Guinea J, Hagen F, Hochhegger B, Hoenigl M, Husain S, Jabeen K, Jensen HE, Kanj SS, Koehler P, Lehrnbecher T, Lewis RE, Meis JF, Nguyen MH, Pana ZD, Rath P-M, Reinhold I, Seidel D, Takazono T, Vinh DC, Zhang SX, Afeltra J, Al-Hatmi AMS, Arastehfar A, Arikan-Akdagli S, Bongomin F, Carlesse F, Chayakulkeeree M, Chai LYA, Chamani-Tabriz L, Chiller T, Chowdhary A, Clancy CJ, Colombo AL, Cortegiani A, Corzo Leon DE, Drgona L, Dudakova A, Farooqi J, Gago S, Ilkit M, Jenks JD, Klimko N, Krause R, Kumar A, Lagrou K, Lionakis MS, Lmimouni BE, Mansour MK, Meletiadis J, Mellinghoff SC, Mer M, Mikulska M, Montravers P, Neoh CF, Ozenci V, Pagano L, Pappas P, Patterson TF, Puerta-Alcalde P, Rahimli L, Rahn S, Roilides E, Rotstein C, Ruegamer T, Sabino R, Salmanton-Garc\u00eda J, Schwartz IS, Segal E, Sidharthan N, Singhal T, Sinko J, Soman R, Spec A, Steinmann J, Stemler J, Taj-Aldeen SJ, Talento AF, Thompson GR III, Toebben C, Villanueva-Lozano H, Wahyuningsih R, Weinbergerov\u00e1 B, Wiederhold N, Willinger B, Woo PCY, Zhu L-P (2025) Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis 25:e280\u2013e293","journal-title":"Lancet Infect Dis"},{"key":"8151_CR69","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1124\/pharmrev.122.000810","volume":"75","author":"W Sadee","year":"2023","unstructured":"Sadee W, Wang D, Hartmann K, Toland AE (2023) Pharmacogenomics: driving personalized medicine. Pharmacol Rev 75:789\u2013814","journal-title":"Pharmacol Rev"},{"key":"8151_CR70","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00134-025-07793-5","volume":"51","author":"JA Roberts","year":"2025","unstructured":"Roberts JA, Sime FB, Lipman J, Hern\u00e1ndez-Mitre MP, Baptista JP, Br\u00fcggemann RJ, Darvall J, De Waele JJ, Dimopoulos G, Lefrant JY, Mat Nor MB, Rello J, Seoane L, Slavin MA, Valkonen M, Venditti M, Ceccarelli G, Wong WT, Zeitlinger M, Roger C (2025) Are contemporary antifungal doses sufficient for critically ill patients? outcomes from an international, multicenter pharmacokinetics study for screening antifungal exposure in intensive care units-the SAFE-ICU study. Intensive Care Med 51:302\u2013317","journal-title":"Intensive Care Med"},{"key":"8151_CR71","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA (2020) Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper(). Intensive Care Med 46:1127\u20131153","journal-title":"Intensive Care Med"},{"key":"8151_CR72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1473-3099(23)00551-0","volume":"24","author":"GR Thompson III","year":"2024","unstructured":"Thompson GR III, Soriano A, Honore PM, Bassetti M, Cornely OA, Kollef M, Kullberg BJ, Pullman J, Hites M, Fort\u00fan J, Horcajada JP, Kotanidou A, Das AF, Sandison T, Aram JA, Vazquez JA, Pappas PG (2024) Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials. Lancet Infect Dis 24:319\u2013328","journal-title":"Lancet Infect Dis"},{"key":"8151_CR73","doi-asserted-by":"publisher","unstructured":"Hodges MR, Tawadrous M, Cornely OA, Thompson GR, 3rd, Slavin MA, Maertens JA, Dadwal SS, Rahav G, Hazel S, Almas M, Jakate A, Pypstra R, (2025) Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS). Clin Infect Dis ciaf185. https:\/\/doi.org\/10.1093\/cid\/ciaf185 [Online ahead of print]","DOI":"10.1093\/cid\/ciaf185"},{"key":"8151_CR74","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/jac\/dkad256","volume":"78","author":"PG Pappas","year":"2023","unstructured":"Pappas PG, Vazquez JA, Oren I, Rahav G, Aoun M, Bulpa P, Ben-Ami R, Ferrer R, Mccarty T, Thompson GR III, Schlamm H, Bien PA, Barbat SH, Wedel P, Oborska I, Tawadrous M, Hodges MR (2023) Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial. J Antimicrob Chemother 78:2471\u20132480","journal-title":"J Antimicrob Chemother"},{"key":"8151_CR75","doi-asserted-by":"publisher","first-page":"e01324","DOI":"10.1128\/aac.01324-23","volume":"68","author":"AM Aldejohann","year":"2024","unstructured":"Aldejohann AM, Menner C, Thielemann N, Martin R, Walther G, Kurzai O (2024) In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrob Agents Chemother 68:e01324-e11323","journal-title":"Antimicrob Agents Chemother"},{"key":"8151_CR76","first-page":"e00074","volume":"0","author":"M Hoenigl","year":"2024","unstructured":"Hoenigl M, Arastehfar A, Arendrup Maiken C, Br\u00fcggemann R, Carvalho A, Chiller T, Chen S, Egger M, Feys S, Gangneux J-P, Gold Jeremy AW, Groll Andreas H, Heylen J, Jenks Jeffrey D, Krause R, Lagrou K, Lamoth F, Prattes J, Sedik S, Wauters J, Wiederhold Nathan P, Thompson George R (2024) Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clin Microbiol Rev 0:e00074-e123","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"8151_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.02694-20","volume":"65","author":"NP Wiederhold","year":"2021","unstructured":"Wiederhold NP, Najvar LK, Olivo M, Morris KN, Patterson HP, Catano G, Patterson TF (2021) Ibrexafungerp demonstrates in vitro activity against fluconazole-resistant candida auris and in vivo efficacy with delayed initiation of therapy in an experimental model of invasive candidiasis. Antimicrob Agent Chemother 65(6):10\u20131128","journal-title":"Antimicrob Agent Chemother"},{"issue":"Suppl 4","key":"8151_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1469-0691.2008.01983.x","volume":"14","author":"L Ostrosky-Zeichner","year":"2008","unstructured":"Ostrosky-Zeichner L (2008) Combination antifungal therapy: a critical review of the evidence. Clin Microbiol Infect 14(Suppl 4):65\u201370","journal-title":"Clin Microbiol Infect"},{"key":"8151_CR79","doi-asserted-by":"publisher","first-page":"ofae646","DOI":"10.1093\/ofid\/ofae646","volume":"11","author":"SE Jacobs","year":"2024","unstructured":"Jacobs SE, Chaturvedi V (2024) CAF to the rescue! potential and challenges of combination antifungal therapy for reducing morbidity and mortality in hospitalized patients with serious fungal infections. Open Forum Infect Dis 11:ofae646","journal-title":"Open Forum Infect Dis"},{"key":"8151_CR80","first-page":"204993612311613","volume":"10","author":"LSM Sigera","year":"2023","unstructured":"Sigera LSM, Denning DW (2023) Flucytosine and its clinical usage. Ther Adv Infect Dis 10:20499361231161388","journal-title":"Ther Adv Infect Dis"},{"key":"8151_CR81","doi-asserted-by":"publisher","first-page":"100658","DOI":"10.1016\/j.lanepe.2023.100658","volume":"30","author":"R Sprute","year":"2023","unstructured":"Sprute R, Duda S, Liekweg A, Simon M, Cornely OA (2023) The silent flucytosine shortage in Europe - not a distant problem. Lancet Reg Health Eur 30:100658","journal-title":"Lancet Reg Health Eur"},{"key":"8151_CR82","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.medin.2019.06.008","volume":"44","author":"J Vall\u00e8s","year":"2020","unstructured":"Vall\u00e8s J, Fern\u00e1ndez S, Cort\u00e9s E, Mor\u00f3n A, Fondevilla E, Oliva JC, Diaz E (2020) Comparison of the defined daily dose and days of treatment methods for evaluating the consumption of antibiotics and antifungals in the intensive care unit. Med Intensiva (Engl Ed) 44:294\u2013300","journal-title":"Med Intensiva (Engl Ed)"},{"key":"8151_CR83","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cmi.2020.05.037","volume":"26","author":"A G\u00f3mez-L\u00f3pez","year":"2020","unstructured":"G\u00f3mez-L\u00f3pez A (2020) Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation. Clin Microbiol Infect 26:1481\u20131487","journal-title":"Clin Microbiol Infect"},{"key":"8151_CR84","doi-asserted-by":"publisher","first-page":"e00142","DOI":"10.1128\/cmr.00142-23","volume":"37","author":"E Puumala","year":"2024","unstructured":"Puumala E, Fallah S, Robbins N, Cowen LE (2024) Advancements and challenges in antifungal therapeutic development. Clin Microbiol Rev 37:e00142-e1123","journal-title":"Clin Microbiol Rev"},{"key":"8151_CR85","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2147\/IDR.S249864","volume":"13","author":"M Ademe","year":"2020","unstructured":"Ademe M, Girma F (2020) Candida auris: From Multidrug Resistance to Pan-Resistant Strains. Infect Drug Resist 13:1287\u20131294","journal-title":"Infect Drug Resist"},{"key":"8151_CR86","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1093\/jac\/dkac344","volume":"77","author":"R Sprute","year":"2022","unstructured":"Sprute R, Grothe JH, Heringer S, Cornely OA (2022) Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis. J Antimicrob Chemother 77:3475\u20133481","journal-title":"J Antimicrob Chemother"},{"key":"8151_CR87","doi-asserted-by":"publisher","first-page":"e0162721","DOI":"10.1128\/AAC.01627-21","volume":"66","author":"AS Komorowski","year":"2022","unstructured":"Komorowski AS, Bai AD, Cvetkovic A, Mourad O, Lo CKL, Li XX, Mokashi V, Findlater A, Duncan DB, Fuller C, Leto DL, Yamamura D, Mertz D (2022) Secondary analysis of a systematic review: are antifungal noninferiority trials at risk of eroding effectiveness because of biocreep? Antimicrob Agents Chemother 66:e0162721","journal-title":"Antimicrob Agents Chemother"},{"key":"8151_CR88","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/myc.12616","volume":"60","author":"A Armaganidis","year":"2017","unstructured":"Armaganidis A, Nanas S, Antoniadou E, Mandragos K, Liakou K, Koutsoukou A, Baltopoulos G, Nakos G, Kounougeri A, Ganas K, Prekates A, Kompoti M, Georgopoulos D, Pneumatikos I, Zakynthinos E (2017) Clinical factors affecting costs in patients receiving systemic antifungal therapy in intensive care units in Greece: results from the ESTIMATOR study. Mycoses 60:454\u2013461","journal-title":"Mycoses"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-025-08151-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:09:15Z","timestamp":1764180555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-025-08151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":88,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["8151"],"URL":"https:\/\/doi.org\/10.1007\/s00134-025-08151-1","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ignacio Martin-Loeches reports speaker fees and\/or research funding from Mundipharma, Gilead, Pfizer, MSD, and Menarini. Oliver A. Cornely reports grants or contracts from iMi, iHi, DFG, BMBF, Cidara, DZIF, EU-DG RTD, F2G, Gilead, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis; consulting fees from numerous companies, including AbbVie, GSK, IQVIA, Janssen, MedPace, Menarini, and Shionogi; speaker and lecture honoraria from various institutions and industry partners; expert testimony for Cidara; and participation on advisory boards. David W. Denning holds founder shares in F2G Ltd., a University of Manchester spin-out antifungal discovery company; is or has recently been a consultant to Pulmatrix, Pulmocide, Biosergen, TFF Pharmaceuticals, Pfizer, Omega, Novacyt, Rostra Pharmaceuticals, MucPharm, Mundipharma, Lifemine, and Cipla; chairs a Data Review Committee for Pulmocide and acts as a Phase 1 Medical Monitor for Biosergen; has been paid for talks on behalf of BioRad, Basilea, and Pfizer; and is a longstanding member of the Infectious Disease Society of America Aspergillosis Guidelines group and the European Society for Clinical Microbiology and Infectious Diseases Aspergillosis Guidelines group, and recently joined the One World Guideline for Aspergillosis. Jes\u00fas Guinea has received funds for educational activities and research from Gilead, Pfizer, Mundipharma, FIS, F2G, Shionogi, and Scynexis. Matteo Bassetti declares consulting and research support from Advanz, Cidara, Gilead, Menarini, MSD, Pfizer, Shionogi, and Mundipharma. Johan Maertens reports grants, consultancy, and speaker fees from F2G, Gilead, MSD, Pfizer, Mundipharma, and others; has received expert witness payments from Cidara, Mundipharma, and F2G. Martin Hoenigl reports grants and research funding from Gilead, Astellas, MSD, IMMY, Pulmocide, Shionogi, GSK, Melinta, Mundipharma, Scynexis, F2G, and Pfizer, unrelated to the current work. Souha S. Kanj reports speaker and advisory roles for Pfizer, MSD, Menarini, Hikma, and Astellas. Monica Slavin is a speaker and\/or advisory board member for Pfizer, Gilead, Merck Sharp & Dohme (MSD), and F2G; and has received research support from Pfizer, Gilead, MSD, and F2G. Luis Ostrosky-Zeichner has received research funding and\/or consulting honoraria from the following companies: Scynexis, Melinta, GSK, Pulmocide, F2G, Basilea, Pfizer, Gilead, T2 Biosystems, Octapharma, Meiji, Knight, and Eurofins Viracor. He is partially funded by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through UTHealth-CCTS Grant Number UL1TR003167 and contract U01CK000692, Centers for Disease Control and Prevention. Patricia Mu\u00f1oz has served as a speaker and\/or consultant for Basilea, Gilead, MSD, Mundipharma, Pfizer, Roche, Pharmamar SAU, and Menarini; received support from Fundaci\u00f3n de Ciencias de la Salud, UIMP, Future Day Foundation, and Fundaci\u00f3n SEIMC-GESIDA; and research funding from Pharmamar, FIS, CIBERES, Mutua Madrile\u00f1a, EU funds, and Fundaci\u00f3n P\u00fablica Andaluza.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}